We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
Cap. Flow
+$8.89B
Cap. Flow %
8.09%
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.35B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.85B
3
LLY icon
Eli Lilly
LLY
+$999M
4
KO icon
Coca-Cola
KO
+$685M
5
AVGO icon
Broadcom
AVGO
+$616M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.38B
2
AAPL icon
Apple
AAPL
+$1.12B
3
NFLX icon
Netflix
NFLX
+$678M
4
BSX icon
Boston Scientific
BSX
+$671M
5
COR icon
Cencora
COR
+$627M

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Consumer Discretionary 12.77%
3 Healthcare 10.45%
4 Financials 7.74%
5 Communication Services 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANRO icon
1301
Alto Neuroscience
ANRO
$1.01B
$3.44M ﹤0.01%
193,109
-632,116
-77% -$7.96M
CSAN icon
1302
Cosan
CSAN
$2.96B
$3.43M ﹤0.01%
868,927
+843,051
+3,258% +$3.84M
FOLD
1303
DELISTED
Amicus Therapeutics
FOLD
$3.43M ﹤0.01%
+240,900
New +$2.37M
INOD icon
1304
Innodata
INOD
$2.03B
$3.43M ﹤0.01%
+67,284
New +$4.39M
OCGN icon
1305
Ocugen
OCGN
$450M
$3.42M ﹤0.01%
+2,530,956
New +$3.6M
RGLD icon
1306
Royal Gold
RGLD
$15.9B
$3.39M ﹤0.01%
15,246
-149,108
-91% -$29.6M
CRVL icon
1307
CorVel
CRVL
$3.13B
$3.38M ﹤0.01%
+49,948
New +$3.62M
KIE icon
1308
State Street SPDR S&P Insurance ETF
KIE
$619M
$3.36M ﹤0.01%
+55,867
New +$3.29M
CLVT icon
1309
Clarivate
CLVT
$1.49B
$3.36M ﹤0.01%
1,006,001
-319,109
-24% -$1.13M
KD icon
1310
Kyndryl
KD
$2.69B
$3.35M ﹤0.01%
+126,244
New +$3.42M
MIST icon
1311
Milestone Pharmaceuticals
MIST
$147M
$3.35M ﹤0.01%
1,656,821
+1,231,793
+290% +$2.65M
RING icon
1312
iShares MSCI Global Gold Miners ETF
RING
$2.17B
$3.34M ﹤0.01%
+45,300
New +$3.06M
ALT icon
1313
Altimmune
ALT
$546M
$3.33M ﹤0.01%
+922,777
New +$4.02M
ALTO icon
1314
Alto Ingredients
ALTO
$427M
$3.32M ﹤0.01%
+1,154,138
New +$2.18M
HELE icon
1315
Helen of Troy
HELE
$652M
$3.32M ﹤0.01%
+156,093
New +$3.18M
NSPR icon
1316
InspireMD
NSPR
$33M
$3.31M ﹤0.01%
1,860,405
ALIT icon
1317
Alight
ALIT
$536M
$3.31M ﹤0.01%
84,886
+76,834
+954% +$3.83M
NNN icon
1318
NNN REIT
NNN
$9.31B
$3.3M ﹤0.01%
+83,237
New +$3.41M
EYE icon
1319
National Vision
EYE
$1.61B
$3.3M ﹤0.01%
127,685
-10,264
-7% -$276K
FRMI
1320
Fermi Inc
FRMI
$3.91B
$3.29M ﹤0.01%
+411,283
New +$8.02M
VVX icon
1321
V2X
VVX
$2.38B
$3.29M ﹤0.01%
60,315
-1,604
-3% -$90.2K
VCEL icon
1322
Vericel Corp
VCEL
$2.34B
$3.28M ﹤0.01%
+91,216
New +$3.35M
OVV icon
1323
Ovintiv
OVV
$16.2B
$3.28M ﹤0.01%
83,812
+33,673
+67% +$1.31M
LWLG icon
1324
Lightwave Logic
LWLG
$917M
$3.28M ﹤0.01%
1,013,735
+992,129
+4,592% +$4.4M
MA icon
1325
Mastercard
MA
$484B
$3.28M ﹤0.01%
5,753
-218,903
-97% -$122M

Similar funds

Marshall Wace's Q4 2025 Portfolio in Review

As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.

  • Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
  • Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
  • Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
  • Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
  • Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.